Ultrasound

While radiologists and other providers may be discouraged by insurer denials saying the use of a technological advance is “unproven and investigational,” 82 percent of appeals for prior authorization denials were approved in 2021.

In a recent lecture at the 2024 ARRS Annual Meeting, Jordana Phillips, MD, discussed the role of contrast-enhanced mammography in staging breast cancer, evaluating response to neoadjuvant chemotherapy and recalls from screening.

In a recent interview, Stacy Smith-Foley, M.D., shared her perspective on the shortcomings of the recently issued breast cancer screening recommendations from the United States Preventive Services Task Force (USPSTF).

In a recent interview, Steven Raman, M.D., discussed the use of MRI-guided transurethral ultrasound (TULSA) in the treatment of intermediate risk prostate cancer and key research findings with one- and five-year outcomes.

Catch up on the top radiology content of the past week.

Catch up on the top AI-related news and research in radiology over the past month.

An emerging deep learning radiomics model, based on B-mode ultrasound and color Doppler flow imaging, demonstrated a 91 percent AUC for predicting lymphovascular invasion in a multicenter study of women with invasive breast cancer.

One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.

The artificial intelligence (AI)-powered applications reportedly allow clinicians to diagnose pulmonary edema and measure left ventricle ejection fraction within seconds.

One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.

Strain imaging analysis is one of the automated parameters included in the newly FDA-cleared Us2.v2 software for adjunctive review of echocardiographic images.

The addition of Caption AI to the handheld ultrasound device Vscan Air SL may facilitate optimal imaging for point-of-care cardiac evaluation.

Catch up on the top radiology content of the past week.

Featuring automated one-click functionality for capturing prostate volume, the AI-enabled software may help shorten workflows for prostate imaging, biopsies, and ultrasound-guided procedures.

A nomogram that combines contrast-enhanced lymphatic ultrasound and grayscale ultrasound findings had an 88 percent AUC for prediction of three or more metastatic axillary lymph nodes in women with early breast cancer.

Catch up on the top AI-related news and research in radiology over the past month.

Catch up on the top radiology content of the past week.

A multiparametric ultrasound model emphasizing attenuation coefficient assessment demonstrated a 77 percent AUC for detecting metabolic dysfunction-associated steatohepatitis (MASH), according to validation testing from a new multicenter study.

For men with prostate cancer, the use of MRI-guided transurethral ultrasound ablation (TULSA) led to a 92 percent decrease in median prostate volume at one year, according to new research recently presented at Society of Interventional Radiology (SIR) conference.

Catch up on the top radiology content of the past week.

In a comparison of image-to-text large language models (LLMs), ChatGPT 4.0 offered a 95 percent sensitivity rate and an 83 percent AUC that were comparable to that of two senior radiologists and one junior radiologist interacting with LLM to differentiate between malignant and benign thyroid nodules on ultrasound.

Catch up on the top radiology content of the past week.

While adjunctive use of AI led to significantly higher specificity and accuracy rates in detecting cancer on breast ultrasound exams in comparison to unassisted reading by breast radiologists, researchers noted that 12 of 13 BI-RADS 3 lesions upgraded by AI were ultimately benign, according to research presented at the European Congress of Radiology.

A recent pediatric clinical trial revealed that left ventricular opacification with the ultrasound agent Definity improved ejection fraction assessment for 80 percent of patients.

Designed for full-body imaging, the new modality reportedly offers a lightweight portable design, AI-powered tools and enhanced high-resolution images.